Advanced Solid Tumors: PM54 Treatment

We are testing a new treatment called PM54 for patients with advanced solid tumors. The goal is to evaluate its safety and how well it works compared to existing options.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Grand Hopital De Charleroi
Medical Oncology
Gilly, Belgium
Institut Jules Bordet
Clinical Trial Conduct Unit
Negenmanneke, Belgium
Universitair Ziekenhuis Antwerpen
Medical Oncology
Wilrijk, Belgium

Sponsor: Pharma Mar S.A.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.